Status:
COMPLETED
An Investigation of Effectiveness and Safety of Varenicline Tartrate in Helping People Quit Smoking
Lead Sponsor:
Pfizer
Conditions:
Smoking Cessation
Eligibility:
All Genders
18-75 years
Phase:
PHASE3
Brief Summary
To investigate safety and efficacy of varenicline tartrate in helping people quit smoking
Eligibility Criteria
Inclusion
- Current cigarette smokers between the ages of 18 and 75 years, who are motivated to stop smoking
Exclusion
- Patients currently suffering from depression, or have been diagnosed with depression in the last 12 months, or subjects with past or present history of psychosis, panic disorder, or bipolar disorder
- Any subject with known severe chronic obstructive pulmonary disease (COPD)
Key Trial Info
Start Date :
September 1 2006
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2007
Estimated Enrollment :
334 Patients enrolled
Trial Details
Trial ID
NCT00371813
Start Date
September 1 2006
End Date
June 1 2007
Last Update
April 22 2015
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Shenyang, Liaoning, China, 110016
2
Pfizer Investigational Site
Beijing, China, 100020
3
Pfizer Investigational Site
Beijing, China, 100029
4
Pfizer Investigational Site
Beijing, China, 100036